Your prescriber will assess your medical history, current medications, and BMI before recommending it
In the New England Journal of Medicine, Garvey and colleagues [5] report the results of the REDEFINE 1 trial, a 68-week, phase 3a double-blind, placebo-controlled and active-controlled trial evaluating the efficacy and safety of coadministered cagrilintide and semaglutide in adults with obesity [body mass index (BMI) 30 kg/m 2 ] or overweight (BMI 27 kg/m 2 ) with at least one weight-related comorbidity
On May 9, 2024, significant advancements were made in the Ozempic multidistrict litigation (MDL), currently underway in Philadelphia
Patients are taught proper subcutaneous injection technique for the abdomen, thigh, or upper arm, rotating sites to prevent tissue irritation
Blood sugar levels typically improve within 2-4 weeks of starting Ozempic, while noticeable weight loss usually begins after 8-12 weeks of consistent use with either medication